Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tcr-T Cells
Esophageal Cancer
Beijing Geekgene Technology Co., LTD
P1/2
CC
(41)
Tcr-T Cells
Gastric Cancer
Beijing Geekgene Technology Co., LTD
P1/2
CC
(41)
Tmpsma-02
Metastatic Prostate Carcinoma
Tceleron Therapeutics, Inc.
P1/2
CC
(41)
vor33
Myelodysplastic Syndrome
Vor Biopharma
P1/2
CC
(41)
White Blood Cells/Granulocytes
Neoplasm
Dipnarine Maharaj
P1/2
CC
(41)
Allogeneic Natural Killer Cells
B-Cell Non-Hodgkin Lymphoma
Paolo Caimi, MD
P1
CC
(40)
Allogeneic Natural Killer Cells
Primary Mediastinal Large B-Cell Lymphoma
Paolo Caimi, MD
P1
CC
(40)
Allogeneic Natural Killer Cells
Neoplasm
Beijing Kejing Biotechnology Co., Ltd.
P1
CC
(40)
Car-Nk-Cd19 Cells
Acute Lymphoblastic Leukemia
Shanghai Simnova Biotechnology Co.,Ltd.
P1
CC
(40)
Cb Car-Nk18.2
Gastric Cancer
Zhejiang Provincial People's Hospital
P1
CC
(40)
Expanded Cb-Nk Cells
Colon Carcinoma
M.D. Anderson Cancer Center
P1
CC
(40)
ibr854 cell
Neoplasm
Imbioray (Hangzhou) Biomedicine Co., Ltd.
P1
CC
(40)
Iepcs
Ischemic Stroke
Allife Medical Science and Technology Co., Ltd.
P1
CC
(40)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor
Mantle Cell Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
P1
CC
(40)
Nadravaleucel
Hodgkins Lymphoma
David Wald
P1
CC
(40)
Prgn-3007
Acute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(40)
Prgn-3007
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(40)
Prgn-3007
Mantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(40)
T-Cell Receptor-Engineered T-Cells
Prostate Small Cell Carcinoma
Fred Hutchinson Cancer Center
P1
CC
(40)
T-Cell Receptor-Engineered T-Cells
Prostate Cancer
Fred Hutchinson Cancer Center
P1
CC
(40)
4scar t cells
Breast Cancer
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
a2b395
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b530
Colorectal Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b530
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(40)
a2b530
Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(40)
Showing 2151 to 2175 of 3,186 assets
Previous
Page 87 of 128
Next